Pathway-based classification of lung cancer: A strategy to guide therapeutic selection

Proceedings of the American Thoracic Society

Volumn 8, Issue 2, 2011, Pages 180-182

  Nevins, Joseph R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Genomics; Lung cancer; Pathway signatures

Indexed keywords

CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR 2; RAS PROTEIN; TRASTUZUMAB; TUMOR MARKER;

BREAST CANCER; CANCER CELL CULTURE; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER RELAPSE; CLINICAL PRACTICE; COLON CANCER; CONFERENCE PAPER; GENE EXPRESSION; GENE MUTATION; GENOMICS; HUMAN; LUNG NON SMALL CELL CANCER; MOLECULARLY TARGETED THERAPY; ONCOGENE K RAS; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; HUMANS; LUNG NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 80051757489     PISSN: 15463222     EISSN: 19435665     Source Type: Journal    
DOI: 10.1513/pats.201006-040MS     Document Type: Conference Paper

References (4)

1. West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R, Zuzan H, Olson JA Jr, Marks JR, Nevins JR. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA 2001;98:11462-11467. (Pubitemid 32928751)
2. Huang E, Ishida S, Pittman J, Dressman H, West M, Nevins JR. Gene expression phenotypic models that predict the activity of oncogenic pathways. Nat Genet 2003;34:226-230. (Pubitemid 36666937)
3. Bild A, Yao G, Chang JT, Wang Q, Potti A, Chasse D, Joshi M-B, Harpole D, Lancaster JM, Berchuck A, et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006;439:353-357. (Pubitemid 43128862)
4. Gatza ML, Lucas JE, Barry WT, Kim J-W, Wang Q, Crawford M, Datto M, Kelley M, Mathey-Prevot B, Potti A, et al. A pathway-based classification of human breast cancer. Proc Natl Acad Sci USA 2010; 107:6994-6999.